Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-16 5:24 pm Purchase |
2024-01-11 | 13G | Aclaris Therapeutics, Inc. ACRS |
BML Investment Partners, L.P. | 4,500,000 6.400% |
4,500,000 (New Position) |
Filing History |
| 2023-12-11 4:25 pm Purchase |
2023-12-07 | 13G | Aclaris Therapeutics, Inc. ACRS |
MILLENNIUM MANAGEMENT LLC | 3,588,114 5.100% |
3,588,114 (New Position) |
Filing History |
| 2023-12-11 09:36 am Sale |
2023-11-30 | 13G | Aclaris Therapeutics, Inc. ACRS |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-7,372,601 (Position Closed) |
Filing History |
| 2023-11-24 1:49 pm Purchase |
2023-11-14 | 13G | Aclaris Therapeutics, Inc. ACRS |
TANG CAPITAL PARTNERS LP | 4,338,155 6.100% |
4,338,155 (New Position) |
Filing History |
| 2023-09-05 4:14 pm Purchase |
2023-08-25 | 13G | Aclaris Therapeutics, Inc. ACRS |
Citadel Advisors LLC | 3,586,764 5.100% |
3,586,764 (New Position) |
Filing History |
| 2023-04-10 09:06 am Purchase |
2023-03-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
WELLINGTON MANAGEMENT CO LLP | 7,372,601 11.050% |
1,888,588 (+34.44%) |
Filing History |
| 2023-03-16 4:48 pm Purchase |
2023-03-06 | 13G | Aclaris Therapeutics, Inc. ACRS |
BIOTECHNOLOGY VALUE FUND L P | 3,360,941 5.000% |
84,398 (+2.58%) |
Filing History |
| 2023-02-14 2:49 pm Purchase |
2022-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Rock Springs Capital Management LP | 3,961,249 5.940% |
99,902 (+2.59%) |
Filing History |
| 2023-02-14 11:40 am Sale |
2022-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
BIOTECHNOLOGY VALUE FUND L P | 3,276,543 4.900% |
-591,500 (-15.29%) |
Filing History |
| 2023-02-13 5:06 pm Purchase |
2022-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Foresite Capital Fund IV, L.P. | 4,066,277 6.100% |
4,066,277 (New Position) |
Filing History |
| 2023-02-06 2:43 pm Sale |
2022-12-30 | 13G | Aclaris Therapeutics, Inc. ACRS |
WELLINGTON MANAGEMENT CO LLP | 5,484,013 8.220% |
-55,255 (-1.00%) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
BLACKROCK INC BLK |
5,087,435 7.600% |
1,008,560 (+24.73%) |
Filing History |
| 2022-04-25 4:30 pm Purchase |
2022-04-13 | 13G | Aclaris Therapeutics, Inc. ACRS |
RA Capital Management, L.P. | 4,398,453 7.100% |
4,398,453 (New Position) |
Filing History |
| 2022-02-14 6:22 pm Purchase |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Rock Springs Capital Management LP | 3,861,347 6.310% |
1,185,247 (+44.29%) |
Filing History |
| 2022-02-14 4:13 pm Purchase |
2021-01-19 | 13G | Aclaris Therapeutics, Inc. ACRS |
Venrock Healthcare Capital Partners II, L.P. | 4,563,962 7.500% |
4,563,962 (New Position) |
Filing History |
| 2022-02-11 3:12 pm Sale |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Foresite Capital Fund III L.P. | 4,657,277 7.600% |
-1,954,904 (-29.57%) |
Filing History |
| 2022-02-10 2:17 pm Sale |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Renaissance Technologies LLC | 1,676,878 2.740% |
-1,591,300 (-48.69%) |
Filing History |
| 2022-02-10 08:54 am Sale |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
ADAGE CAPITAL PARTNERS GP LLC | 899,997 1.470% |
-1,350,003 (-60.00%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
BLACKROCK INC BLK |
4,078,875 6.700% |
3,031,059 (+289.27%) |
Filing History |
| 2022-02-04 09:12 am Purchase |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
WELLINGTON MANAGEMENT CO LLP | 5,539,268 9.050% |
5,539,268 (New Position) |
Filing History |